Open Access
Volume 18, Number 4, Juillet-Août 2011
Lipids and Brain II. Actes des Journées Chevreul 2011 (Première partie)
Page(s) 199 - 201
Section PUFA and Depression
Published online 15 July 2011
  • Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990 ; 82 : 209–216. [CrossRef] [PubMed] [Google Scholar]
  • Estilaei MR, Matson GB, Payne GS, et al. Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS study. Alcohol Clin Exp Res 2001 ; 25 : 89–97. [CrossRef] [PubMed] [Google Scholar]
  • Friston KJ. Analysing brain image: principles and overview. In: Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC (Eds.), Human brain function. London: Academic Press, 1997: 25–41. [Google Scholar]
  • Friston K. Statistical parametric mapping In: Friston KJ, Ashburner JT, Kiebel SJ, Nichols TE, Penny WD (Eds.), Statistical parametric mapping: The analysis of functional brain images. London: Academic Press, 2007: 10–31. [Google Scholar]
  • Horrobin DF. Post-viral fatigue syndrome, viral infections in atopic eczema, and essential fatty acids. Med Hypotheses 1990 ; 32 : 211–217. [CrossRef] [PubMed] [Google Scholar]
  • Kilby PM, Allis JL, Radda GK. Spin-spin relaxation of the phosphodiester resonance in the 31P NMR spectrum of human brain. The determination of the concentrations of phosphodiester components. FEBS Lett 1990 ; 272 : 163–165. [CrossRef] [PubMed] [Google Scholar]
  • Puri BK, Richardson AJ, Horrobin DF, et al. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int J Clin Pract 2000 ; 54 : 57–63. [PubMed] [Google Scholar]
  • Puri BK, Counsell SJ, Hamilton G, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. Int J Clin Pract 2001 ; 55 : 560–563. [PubMed] [Google Scholar]
  • Puri BK, Bydder GM, Counsell SJ, et al. MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment. Neuroreport 2002 ; 13 : 123–126. [CrossRef] [PubMed] [Google Scholar]
  • Puri BK. Monomodal rigid-body registration and applications to the investigation of the effects of eicosapentaenoic acid intervention in neuropsychiatric disorders. Prostaglandins Leukot Essent Fatty Acids 2004 ; 71 : 177–179. [CrossRef] [PubMed] [Google Scholar]
  • Puri BK, Holmes J, Hamilton G. Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes. Int J Clin Pract 2004 ; 58 : 297–299. [CrossRef] [PubMed] [Google Scholar]
  • Puri BK, Counsell SJ, Hamilton G, Bustos MG, Treasaden IH. Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended. Prog Neuropsychopharmacol Biol Psychiatry 2008 ; 32 : 751–754. [Google Scholar]
  • Puri BK, Counsell SJ, Hamilton G. Brain cell membrane motion-restricted phospholipids: A cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids 2008 ; 79 : 233–235. [CrossRef] [PubMed] [Google Scholar]
  • Puri BK, Jakeman PM, Agour M, et al. Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): A voxel-based morphometry 3T MRI study. Br J Radiol 2011 (in press). [Google Scholar]
  • Roth K, Kimber BJ. Determination of optimal parameters in the convolution difference resolution enhancement technique. Org Mag Reson 1982 ; 18 : 197–198. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.